Cvc
13 stories covering cvc — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
CVC Seeks Co-Investment Partners for €10.9bn Recordati Buyout
CVC Capital Partners is pursuing co-investors for its €10.9bn takeover bid of Italian pharmaceutical company Recordati, involving early discussions with specific institutional investors.
CVC Seeks Co-Investment Partners for €10.9bn Recordati Takeover
CVC Capital Partners is pursuing co-investors for its €10.9bn bid to acquire Italian pharmaceutical firm Recordati, involving discussions with major institutional investors.
CVC's Cathrin Petty and Manna Tree's Ellie Rubenstein Named in PE Hub's Women in PE; Blackstone to Launch PMG Sale
PE Hub reports the recognition of two executives in private equity and an upcoming sale by Blackstone, along with another acquisition in legal services.
CVC Proposes €10.9bn Takeover for Recordati
CVC Capital Partners has submitted a non-binding offer to take Recordati private in a €10.9bn deal, according to reports.
CVC Proposes €10.9bn Takeover of Recordati to Take It Private
CVC Capital Partners has submitted a non-binding offer to acquire Recordati for €10.9bn, valuing it at a preliminary €52 per share, according to a report.
Consortium Including Blackstone Acquires IPL Franchise for $1.8 Billion
A group led by Aditya Birla Group buys Royal Challengers Bengaluru for $1.8 billion, with Blackstone making its first investment in a professional sports team.
Apollo and Bain Among Bidders for Continental's ContiTech Unit
Apollo Global Management and Bain Capital are progressing in the auction for Continental AG's ContiTech division, valued at approximately €3.5bn to over €4bn.
Apollo in Talks for Minority Stake in CVC's Syntegon at €4bn Valuation
Apollo Global Management is negotiating a significant minority stake in Syntegon, owned by CVC Capital Partners, at a potential €4bn valuation.
Ardian, CVC, Verdane Eye Investments in Women’s Health; Exellere, GHO Exit Pathology Services Deal
Private equity firms Ardian, CVC, and Verdane target women’s health investments, while Exellere and GHO sell a pathology services company for $950 million.
Ardian, CVC, Verdane Target Women’s Health Investments; Exellere, GHO Exit Pathology Deal
Private equity firms Ardian, CVC, and Verdane are eyeing investments in women’s health, while Exellere Partners and GHO Capital Partners sell a pathology services company for $950 million.
PE Firms Invest in Women's Health Market with 6 Deals
Ardian, Charterhouse, CVC, and L Catterton are among PE firms investing in various women's healthcare segments, according to a recent PE Hub report.
PE Firms Invest in Women's Health Segments: 6 Deals
Ardian, Charterhouse, CVC, and L Catterton are among PE firms backing six deals in various women's healthcare areas, as reported by PE Hub.
CVC Shares Fall After Lower-Than-Expected PRE Outlook
CVC Capital Partners shares dropped on Wednesday due to a disappointing near-term earnings forecast, as reported by Private Equity Wire.
